Intravenous Tenecteplase Plus EVT Versus EVT Alone on 4.5 to 24 Hours After Basilar Artery Occlusion
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 330 participants.
Also called NCT05701956
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 330 participants
- Registry
-
NCT05701956
-
- Other papers using this trial's data
- Tenecteplase Before Thrombectomy at 4.5 to 24 Hours for Basilar Artery Occlusion: The ATTENTION LATE Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT05701956. Randomized; single masking; primary purpose treatment. Start 2023-03-16 (actual); primary completion 2025-02-04 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intravenous Tenecteplase Plus EVT Versus EVT Alone on 4.5 to 24 Hours After Basilar Artery Occlusion
- Condition
- Basilar Artery Occlusion
- Condition
- Acute Cerebrovascular Accident
- Condition
- Stroke Due to Basilar Artery Occlusion
- Intervention (Drug)
- Tenecteplase
- Intervention (Procedure)
- Endovascular thrombectomy
- Lead sponsor
- The First Affiliated Hospital of University of Science and Technology of China
Record details
- Record id
cardio:ct-nct05701956- Content hash
b602bf9788def74848383fe77de39639db8bcdb927d636d65e813d1bcdb1835a